Although Steroids, TNF-α inhibitors, calcitonin, anti-neoplastic agents, immunosuppressants, and monoclonal antibodies have been reported as an option for the pharmacological treatment of cherubism, none have yet been confirmed by clinical trials as a possibility for effective treatment [22–24]. This evidence concerns the gene TNF and cherubism.